Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy

Clinical trial NCT05640713 · UNKNOWN

Trial details

NCT number: NCT05640713
Sponsor: Henan Cancer Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited

Start date: 2022-12-01
Primary completion: 2025-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.